Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Changsha, Hunan, 410011, China
Location status: Recruiting
NCT Number: NCT07621445
The goal of this observational study is to evaluate the predictive value of the genetic risk score for type 1 diabetes in the progression to insulin deficiency in diabetic patients. The main question it aims to answer is:
1. To investigate the predictive efficacy of the genetic risk score for T1DM in determining whether diabetic patients will progress to insulin deficiency; 2. To compare the differences in genetic characteristics between the insulin-deficient cohort and the non-insulin-deficient cohort.
This study is a nested case-control study, in which a case group and a control group are set up for the collection of observational indicators. Case group: Diabetic patients who "progressed to insulin deficiency" and those who "progressed to severe insulin deficiency". Control group: Patients who did not progress to insulin deficiency. The study period is 3 years.
Interested in participating?
Request Info14 year–50 year
All sexes
Observational
Changsha, Hunan, 410011, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: "baseline"、"third year"
The primary endpoint is the occurrence of progression to insulin deficiency. Subjects who "progress to insulin deficiency" are defined as those whose C-peptide level drops to C-peptide < 250 pmol/L during the follow - up period;
Time frame: "baseline"、"third year"
Time frame: "baseline"、"third year"
Time frame: "baseline"、"third year"
Collect the medical history and current medication information of the subjects.
Second Xiangya Hospital of Central South University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07386340
Autoimmune Diseases, Diabetes Mellitus
Escondido, California, United States
View Trial DetailsNCT03648918
Autoimmune Diseases, Diabetes Mellitus
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06405373
Autoimmune Diseases, Diabetes Mellitus
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05910840
Autoimmune Diseases, Diabetes Mellitus
Gatineau, Canada
View Trial Details